Unicycive Therapeutics Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 24 institutions reported holding Unicycive Therapeutics Inc. in their 13F filings, up 1 from Q1 2024. 5 opened new positions and 4 sold out. The largest holders were Vivo Capital, LLC ($1.7M), Logos Global Management LP ($1.7M) and Nantahala Capital Management, LLC ($1.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Unicycive Therapeutics Inc.
- CUSIP
- 90466Y103
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $76K |
| Exits | 4 | $136K |
All 13F filers, Q1 2024 → Q2 2024: 1,001,677 shares bought and 3,251,506 shares sold, net −2,249,829 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vivo Capital, LLC | 0.16% | No change | 3,470,152 | $1.7M |
| Logos Global Management LP | 0.20% | No change | 3,469,927 | $1.7M |
| Nantahala Capital Management, LLC | 0.14% | Reduce -15.4% | 2,820,358 | $1.4M |
| Ra Capital Management, L.P. | 0.02% | Reduce -24.2% | 2,632,200 | $1.3M |
| BVF Inc. | 0.03% | Reduce -39.1% | 2,200,000 | $1.1M |
| Rosalind Advisors, Inc. | 0.62% | Reduce -16.4% | 1,571,200 | $787K |
| Vanguard Group Inc. | 0.00% | Add +234.9% | 1,138,220 | $570K |
| Monashee Investment Management LLC | 0.07% | No change | 1,000,000 | $501K |
| Geode Capital Management, LLC | 0.00% | Add +12.8% | 285,738 | $143K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.0% | 93,352 | $47K |
| LPL Financial LLC | 0.00% | New | 85,000 | $43K |
| BlackRock Inc. | 0.00% | New | 51,837 | $26K |
| State Street Corp. | 0.00% | Add +25.4% | 43,936 | $22K |
| Renaissance Technologies | 0.00% | Reduce -64.3% | 33,200 | $17K |
| Northern Trust Corp. | 0.00% | No change | 23,998 | $12K |
| Captrust Financial Advisors | 0.00% | No change | 18,800 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +140.8% | 18,485 | $9K |
| Tandem Capital Management Corp. | 0.00% | No change | 15,500 | $7K |
| Virtu Financial LLC | 0.00% | Reduce -57.5% | 11,094 | $6K |
| Scientech Research LLC | 0.00% | New | 10,969 | $5K |
| Redwood Wealth Management Group, LLC | 0.00% | New | 3,000 | $2K |
| Bank of America Corp. | 0.00% | New | 223 | $112 |
| JPMorgan Chase & Co. | 0.00% | Add +48.9% | 70 | $35 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is UNICYCIVE THERAPEUTICS INC's weight in each manager's 13F, not the share of Unicycive Therapeutics Inc. the manager owns.